. . "This finding, for the first time, offers scientists a molecular approach to overcome leptin resistance, and provides a target for the development of drugs to treat both obesity and diabetes. ???Since almost all forms of obesity are leptin-resistant, a drug that would act downstream of the leptin receptor could conceivably result in significant weight loss,??? says Neel. ???Since PTP1B additionally" . .